10.25375/uct.7970177.v1 Michele Tameris Michele Tameris Helen Mearns Helen Mearns Adam Penn-Nicholson Adam Penn-Nicholson Yolande Gregg Yolande Gregg Nicole Bilek Nicole Bilek Simbarashe Mabwe Simbarashe Mabwe Hennie Geldenhuys Hennie Geldenhuys Justine Shenje Justine Shenje Angelique Luabeya Angelique Luabeya Ingrid Murillo Ingrid Murillo Juana Doce Juana Doce Nacho Aguilo Nacho Aguilo Dessislava Marinova Dessislava Marinova Esteban Rodriguez Esteban Rodriguez Eugenia Pentes Eugenia Pentes Jesús Gonzalo-Asensio Jesús Gonzalo-Asensio Bernard Fritzell Bernard Fritzell Jelle Thole Jelle Thole Carlos Martin Carlos Martin Thomas Scriba Thomas Scriba Mark Hatherill Mark Hatherill MTBVAC Clinical Trial Team MTBVAC Clinical Trial Team Statistical Analysis Plan University of Cape Town 2019 MTBVAC infants tuberculosis clinical trial Immunology 2019-07-29 12:31:44 Presentation https://zivahub.uct.ac.za/articles/presentation/Statistical_Analysis_Plan/7970177 Statistical analysis plan for the MTBVAC 201 clinical trial. A phase Ib, randomised, double-blind, dose-escalation clinical trial of the safety, reactogenicity and immunogenicity of MTBVAC compared to BCG Vaccine SSI, in newborns living in a tuberculosis endemic region with a safety arm in adults.